Company
Corsair Pharma
Drug Delivery Designed for Daily Life
Also known as Corsair Pharma, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Corsair Pharma, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Corsair Pharma is a clinical-stage company focused on improving the delivery of established medicines to reduce treatment burden and to meaningfully improve patients’ daily lives.
Funding snapshot
- Total raised
- $23MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series B, $23M2023-09-20
Funding rounds
- Series B
- $23M2023-09-20, Company stated
Products
- Other
- TRX-248 Transdermal System
Loading relationship preview